Log in to save to my catalogue

Management of cardiovascular disease by cerium oxide nanoparticles via alleviating oxidative stress...

Management of cardiovascular disease by cerium oxide nanoparticles via alleviating oxidative stress...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dd03c6cccc7f4afd9e612ae5e89eccc7

Management of cardiovascular disease by cerium oxide nanoparticles via alleviating oxidative stress and adipokine abnormalities

About this item

Full title

Management of cardiovascular disease by cerium oxide nanoparticles via alleviating oxidative stress and adipokine abnormalities

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2025-02, Vol.15 (1), p.5709-19

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The current study aimed to evaluate the role of cerium oxide nanoparticles (C-1), a potent antioxidant, in the medication of cardiovascular disease in obese animal model. C-1 was prepared using a modified sonication sol-gel method. Thirty-two adult male rats were equally divided into 4 groups (n=8/each). The first (control) and second (obese) group...

Alternative Titles

Full title

Management of cardiovascular disease by cerium oxide nanoparticles via alleviating oxidative stress and adipokine abnormalities

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_dd03c6cccc7f4afd9e612ae5e89eccc7

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dd03c6cccc7f4afd9e612ae5e89eccc7

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-025-85794-6

How to access this item